Date: 2014-08-26
Type of information: Nomination
Compound:
Company: Nordic Nanovector (Norway)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On August 26, 2014, the Board of Nordic Nanovector has announced the appointment of Luigi Costa as new CEO. Most recently Luigi Costa held the position of Vice President Europe, Middle East and Africa for Onyx Pharmaceuticals, a global biopharmaceutical company based in South San Francisco, California. He was responsible for the startup of the Company’s international organization and for the pre-launch and launch of its Hematology potential blockbuster Kyprolis® outside the US. Prior to joining Onyx Pharmaceuticals, he held several roles of increasing responsibility with Amgen including Head of International Oncology Franchise, General Manager of Italy and Vice President and General Manager of France, the Company’s largest market outside the US.
Financial terms:
Latest news:
